Oral Janus kinase inhibitors in the treatment of atopic dermatitis: A systematic review and meta‐analysis
Abstract Background Janus kinase (JAK) inhibitors are being evaluated as promising upcoming treatments for atopic dermatitis (AD). Objectives To systematically assess the efficacy of oral JAK inhibitors in patients with AD and provide comparisons among JAK inhibitors. Methods A systematic literature...
Saved in:
Main Authors: | Kevin P. Lee (Author), John Plante (Author), Jeffrey E. Korte (Author), Dirk M. Elston (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: Focus on Abrocitinib, Baricitinib, and Upadacitinib
by: Miguel Nogueira, et al.
Published: (2021) -
A case series of acne following Janus kinase inhibitors in patients with atopic dermatitis
by: Sang-Doo Lee, MD, et al.
Published: (2022) -
Comparative Efficacy and Safety of Monoclonal Antibodies and Janus Kinase Inhibitors in Moderate-to-severe Atopic Dermatitis: A Systematic Review and Meta-analysis
by: Farnam B. Sedeh, et al.
Published: (2022) -
Acne keloidalis nuchae in a patient with atopic dermatitis treated with Janus kinase inhibitor upadacitinib
by: Nicolas Caudrelier, MD, et al.
Published: (2023) -
Bridging to a selective Janus kinase 1 inhibitor in severe atopic dermatitis: An instructive case with upadacitinib
by: Jannett Nguyen, MD, et al.
Published: (2021)